01 5Unituxin
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 114
2018 Revenue in Millions : 85
Growth (%) : 34
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 123
2019 Revenue in Millions : 114
Growth (%) : 8
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 202
2020 Revenue in Millions : 123
Growth (%) : 65
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 183
2021 Revenue in Millions : 202
Growth (%) : -10
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 199
2022 Revenue in Millions : 183
Growth (%) : 9
